nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—Feeling abnormal—Phenylpropanolamine—obesity	0.0026	0.00439	CcSEcCtD
Roflumilast—Anxiety—Cimetidine—obesity	0.0026	0.00439	CcSEcCtD
Roflumilast—Constipation—Phentermine—obesity	0.00259	0.00436	CcSEcCtD
Roflumilast—Headache—Benzphetamine—obesity	0.00254	0.00429	CcSEcCtD
Roflumilast—Diarrhoea—Phendimetrazine—obesity	0.00253	0.00427	CcSEcCtD
Roflumilast—Gamma-glutamyltransferase increased—Topiramate—obesity	0.00253	0.00427	CcSEcCtD
Roflumilast—Endocrine disorder—Topiramate—obesity	0.00251	0.00424	CcSEcCtD
Roflumilast—Gastritis—Orlistat—obesity	0.00249	0.0042	CcSEcCtD
Roflumilast—Dizziness—Phendimetrazine—obesity	0.00245	0.00413	CcSEcCtD
Roflumilast—Influenza—Orlistat—obesity	0.00243	0.0041	CcSEcCtD
Roflumilast—Nausea—Benzphetamine—obesity	0.00241	0.00407	CcSEcCtD
Roflumilast—Gastritis—Sibutramine—obesity	0.00241	0.00406	CcSEcCtD
Roflumilast—Urticaria—Phentermine—obesity	0.0024	0.00405	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Diethylpropion—obesity	0.0024	0.00404	CcSEcCtD
Roflumilast—Abdominal pain—Phentermine—obesity	0.00239	0.00403	CcSEcCtD
Roflumilast—Insomnia—Diethylpropion—obesity	0.00238	0.00402	CcSEcCtD
Roflumilast—Influenza—Sibutramine—obesity	0.00235	0.00397	CcSEcCtD
Roflumilast—Hypersensitivity—Phenylpropanolamine—obesity	0.00233	0.00393	CcSEcCtD
Roflumilast—Headache—Phendimetrazine—obesity	0.00232	0.00391	CcSEcCtD
Roflumilast—Dyspepsia—Diethylpropion—obesity	0.00232	0.00391	CcSEcCtD
Roflumilast—Gastrooesophageal reflux disease—Topiramate—obesity	0.0023	0.00389	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Cimetidine—obesity	0.00228	0.00385	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Diethylpropion—obesity	0.00227	0.00383	CcSEcCtD
Roflumilast—Constipation—Diethylpropion—obesity	0.00225	0.0038	CcSEcCtD
Roflumilast—Nausea—Phendimetrazine—obesity	0.0022	0.00371	CcSEcCtD
Roflumilast—Asthenia—Phentermine—obesity	0.00217	0.00366	CcSEcCtD
Roflumilast—Feeling abnormal—Diethylpropion—obesity	0.00217	0.00366	CcSEcCtD
Roflumilast—Infestation—Orlistat—obesity	0.00217	0.00366	CcSEcCtD
Roflumilast—Infestation NOS—Orlistat—obesity	0.00217	0.00366	CcSEcCtD
Roflumilast—Depression—Orlistat—obesity	0.00216	0.00365	CcSEcCtD
Roflumilast—Fatigue—Cimetidine—obesity	0.00216	0.00364	CcSEcCtD
Roflumilast—Constipation—Cimetidine—obesity	0.00214	0.00361	CcSEcCtD
Roflumilast—Pneumonia—Sibutramine—obesity	0.00211	0.00356	CcSEcCtD
Roflumilast—Urinary tract infection—Orlistat—obesity	0.00211	0.00355	CcSEcCtD
Roflumilast—Gastritis—Bupropion—obesity	0.0021	0.00354	CcSEcCtD
Roflumilast—Depression—Sibutramine—obesity	0.00209	0.00353	CcSEcCtD
Roflumilast—Urticaria—Diethylpropion—obesity	0.00209	0.00353	CcSEcCtD
Roflumilast—Dizziness—Phenylpropanolamine—obesity	0.00209	0.00353	CcSEcCtD
Roflumilast—Diarrhoea—Phentermine—obesity	0.00207	0.00349	CcSEcCtD
Roflumilast—Feeling abnormal—Cimetidine—obesity	0.00206	0.00348	CcSEcCtD
Roflumilast—Influenza—Bupropion—obesity	0.00205	0.00346	CcSEcCtD
Roflumilast—Hepatobiliary disease—Orlistat—obesity	0.00205	0.00346	CcSEcCtD
Roflumilast—Urinary tract infection—Sibutramine—obesity	0.00204	0.00344	CcSEcCtD
Roflumilast—Sinusitis—Orlistat—obesity	0.00203	0.00343	CcSEcCtD
Roflumilast—Vomiting—Phenylpropanolamine—obesity	0.00201	0.00339	CcSEcCtD
Roflumilast—Dizziness—Phentermine—obesity	0.002	0.00337	CcSEcCtD
Roflumilast—Rash—Phenylpropanolamine—obesity	0.00199	0.00336	CcSEcCtD
Roflumilast—Dermatitis—Phenylpropanolamine—obesity	0.00199	0.00336	CcSEcCtD
Roflumilast—Sinusitis—Sibutramine—obesity	0.00197	0.00332	CcSEcCtD
Roflumilast—Vomiting—Phentermine—obesity	0.00192	0.00324	CcSEcCtD
Roflumilast—Rash—Phentermine—obesity	0.00191	0.00322	CcSEcCtD
Roflumilast—Dermatitis—Phentermine—obesity	0.0019	0.00321	CcSEcCtD
Roflumilast—Headache—Phentermine—obesity	0.00189	0.0032	CcSEcCtD
Roflumilast—Rhinitis—Sibutramine—obesity	0.00189	0.00318	CcSEcCtD
Roflumilast—Nausea—Phenylpropanolamine—obesity	0.00188	0.00317	CcSEcCtD
Roflumilast—Weight decreased—Bupropion—obesity	0.00185	0.00313	CcSEcCtD
Roflumilast—Hypersensitivity—Cimetidine—obesity	0.00184	0.00311	CcSEcCtD
Roflumilast—Pneumonia—Bupropion—obesity	0.00184	0.0031	CcSEcCtD
Roflumilast—Infestation—Bupropion—obesity	0.00183	0.00308	CcSEcCtD
Roflumilast—Infestation NOS—Bupropion—obesity	0.00183	0.00308	CcSEcCtD
Roflumilast—Diarrhoea—Diethylpropion—obesity	0.0018	0.00304	CcSEcCtD
Roflumilast—Nausea—Phentermine—obesity	0.0018	0.00303	CcSEcCtD
Roflumilast—Asthenia—Cimetidine—obesity	0.0018	0.00303	CcSEcCtD
Roflumilast—Urinary tract infection—Bupropion—obesity	0.00178	0.003	CcSEcCtD
Roflumilast—Immune system disorder—Orlistat—obesity	0.00176	0.00296	CcSEcCtD
Roflumilast—Mediastinal disorder—Orlistat—obesity	0.00175	0.00296	CcSEcCtD
Roflumilast—Dizziness—Diethylpropion—obesity	0.00174	0.00294	CcSEcCtD
Roflumilast—Sinusitis—Bupropion—obesity	0.00171	0.00289	CcSEcCtD
Roflumilast—Diarrhoea—Cimetidine—obesity	0.00171	0.00289	CcSEcCtD
Roflumilast—Mental disorder—Orlistat—obesity	0.0017	0.00288	CcSEcCtD
Roflumilast—Immune system disorder—Sibutramine—obesity	0.0017	0.00287	CcSEcCtD
Roflumilast—Malnutrition—Orlistat—obesity	0.00169	0.00286	CcSEcCtD
Roflumilast—Vomiting—Diethylpropion—obesity	0.00167	0.00282	CcSEcCtD
Roflumilast—Rash—Diethylpropion—obesity	0.00166	0.0028	CcSEcCtD
Roflumilast—Dysgeusia—Orlistat—obesity	0.00166	0.0028	CcSEcCtD
Roflumilast—Dermatitis—Diethylpropion—obesity	0.00166	0.0028	CcSEcCtD
Roflumilast—Dizziness—Cimetidine—obesity	0.00165	0.00279	CcSEcCtD
Roflumilast—Headache—Diethylpropion—obesity	0.00165	0.00278	CcSEcCtD
Roflumilast—Rhinitis—Bupropion—obesity	0.00164	0.00278	CcSEcCtD
Roflumilast—Malnutrition—Sibutramine—obesity	0.00164	0.00277	CcSEcCtD
Roflumilast—Back pain—Orlistat—obesity	0.00164	0.00276	CcSEcCtD
Roflumilast—Muscle spasms—Orlistat—obesity	0.00163	0.00275	CcSEcCtD
Roflumilast—Connective tissue disorder—Bupropion—obesity	0.00161	0.00272	CcSEcCtD
Roflumilast—Tension—Sibutramine—obesity	0.00161	0.00271	CcSEcCtD
Roflumilast—Dysgeusia—Sibutramine—obesity	0.0016	0.00271	CcSEcCtD
Roflumilast—Nervousness—Sibutramine—obesity	0.00159	0.00269	CcSEcCtD
Roflumilast—Vomiting—Cimetidine—obesity	0.00159	0.00269	CcSEcCtD
Roflumilast—Back pain—Sibutramine—obesity	0.00158	0.00267	CcSEcCtD
Roflumilast—Rash—Cimetidine—obesity	0.00158	0.00266	CcSEcCtD
Roflumilast—Dermatitis—Cimetidine—obesity	0.00158	0.00266	CcSEcCtD
Roflumilast—Muscle spasms—Sibutramine—obesity	0.00158	0.00266	CcSEcCtD
Roflumilast—Ill-defined disorder—Orlistat—obesity	0.00157	0.00265	CcSEcCtD
Roflumilast—Headache—Cimetidine—obesity	0.00157	0.00265	CcSEcCtD
Roflumilast—Nausea—Diethylpropion—obesity	0.00156	0.00264	CcSEcCtD
Roflumilast—Angioedema—Orlistat—obesity	0.00155	0.00261	CcSEcCtD
Roflumilast—Tremor—Sibutramine—obesity	0.00153	0.00259	CcSEcCtD
Roflumilast—Malaise—Orlistat—obesity	0.00153	0.00258	CcSEcCtD
Roflumilast—Cardiac disorder—Bupropion—obesity	0.00152	0.00257	CcSEcCtD
Roflumilast—Vertigo—Orlistat—obesity	0.00152	0.00257	CcSEcCtD
Roflumilast—Ill-defined disorder—Sibutramine—obesity	0.00152	0.00257	CcSEcCtD
Roflumilast—Angioedema—Sibutramine—obesity	0.0015	0.00253	CcSEcCtD
Roflumilast—Palpitations—Orlistat—obesity	0.0015	0.00253	CcSEcCtD
Roflumilast—Nausea—Cimetidine—obesity	0.00149	0.00251	CcSEcCtD
Roflumilast—Immune system disorder—Bupropion—obesity	0.00148	0.0025	CcSEcCtD
Roflumilast—Mediastinal disorder—Bupropion—obesity	0.00148	0.0025	CcSEcCtD
Roflumilast—Malaise—Sibutramine—obesity	0.00148	0.00249	CcSEcCtD
Roflumilast—Vertigo—Sibutramine—obesity	0.00147	0.00248	CcSEcCtD
Roflumilast—Palpitations—Sibutramine—obesity	0.00145	0.00244	CcSEcCtD
Roflumilast—Myalgia—Orlistat—obesity	0.00144	0.00243	CcSEcCtD
Roflumilast—Mental disorder—Bupropion—obesity	0.00144	0.00243	CcSEcCtD
Roflumilast—Anxiety—Orlistat—obesity	0.00144	0.00242	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00143	0.00242	CcSEcCtD
Roflumilast—Malnutrition—Bupropion—obesity	0.00143	0.00241	CcSEcCtD
Roflumilast—Discomfort—Orlistat—obesity	0.00142	0.0024	CcSEcCtD
Roflumilast—Tension—Bupropion—obesity	0.0014	0.00237	CcSEcCtD
Roflumilast—Dysgeusia—Bupropion—obesity	0.0014	0.00236	CcSEcCtD
Roflumilast—Myalgia—Sibutramine—obesity	0.00139	0.00235	CcSEcCtD
Roflumilast—Anxiety—Sibutramine—obesity	0.00139	0.00235	CcSEcCtD
Roflumilast—Nervousness—Bupropion—obesity	0.00139	0.00234	CcSEcCtD
Roflumilast—Back pain—Bupropion—obesity	0.00138	0.00233	CcSEcCtD
Roflumilast—Discomfort—Sibutramine—obesity	0.00138	0.00233	CcSEcCtD
Roflumilast—Muscle spasms—Bupropion—obesity	0.00137	0.00232	CcSEcCtD
Roflumilast—Infection—Orlistat—obesity	0.00137	0.00232	CcSEcCtD
Roflumilast—Nervous system disorder—Orlistat—obesity	0.00135	0.00229	CcSEcCtD
Roflumilast—Skin disorder—Orlistat—obesity	0.00134	0.00227	CcSEcCtD
Roflumilast—Tremor—Bupropion—obesity	0.00134	0.00226	CcSEcCtD
Roflumilast—Gastritis—Topiramate—obesity	0.00134	0.00226	CcSEcCtD
Roflumilast—Infection—Sibutramine—obesity	0.00133	0.00224	CcSEcCtD
Roflumilast—Ill-defined disorder—Bupropion—obesity	0.00133	0.00224	CcSEcCtD
Roflumilast—Angioedema—Bupropion—obesity	0.00131	0.0022	CcSEcCtD
Roflumilast—Skin disorder—Sibutramine—obesity	0.0013	0.00219	CcSEcCtD
Roflumilast—Malaise—Bupropion—obesity	0.00129	0.00217	CcSEcCtD
Roflumilast—Vertigo—Bupropion—obesity	0.00128	0.00217	CcSEcCtD
Roflumilast—Palpitations—Bupropion—obesity	0.00126	0.00213	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Orlistat—obesity	0.00126	0.00212	CcSEcCtD
Roflumilast—Insomnia—Orlistat—obesity	0.00125	0.00211	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Sibutramine—obesity	0.00122	0.00206	CcSEcCtD
Roflumilast—Dyspepsia—Orlistat—obesity	0.00122	0.00205	CcSEcCtD
Roflumilast—Myalgia—Bupropion—obesity	0.00122	0.00205	CcSEcCtD
Roflumilast—Anxiety—Bupropion—obesity	0.00121	0.00205	CcSEcCtD
Roflumilast—Insomnia—Sibutramine—obesity	0.00121	0.00204	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00121	0.00204	CcSEcCtD
Roflumilast—Discomfort—Bupropion—obesity	0.0012	0.00203	CcSEcCtD
Roflumilast—Decreased appetite—Orlistat—obesity	0.0012	0.00203	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Orlistat—obesity	0.00119	0.00201	CcSEcCtD
Roflumilast—Fatigue—Orlistat—obesity	0.00119	0.00201	CcSEcCtD
Roflumilast—Weight decreased—Topiramate—obesity	0.00118	0.00199	CcSEcCtD
Roflumilast—Dyspepsia—Sibutramine—obesity	0.00118	0.00199	CcSEcCtD
Roflumilast—Pneumonia—Topiramate—obesity	0.00117	0.00198	CcSEcCtD
Roflumilast—Infestation—Topiramate—obesity	0.00116	0.00197	CcSEcCtD
Roflumilast—Infestation NOS—Topiramate—obesity	0.00116	0.00197	CcSEcCtD
Roflumilast—Decreased appetite—Sibutramine—obesity	0.00116	0.00196	CcSEcCtD
Roflumilast—Depression—Topiramate—obesity	0.00116	0.00196	CcSEcCtD
Roflumilast—Infection—Bupropion—obesity	0.00116	0.00195	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Sibutramine—obesity	0.00115	0.00195	CcSEcCtD
Roflumilast—Constipation—Sibutramine—obesity	0.00114	0.00193	CcSEcCtD
Roflumilast—Nervous system disorder—Bupropion—obesity	0.00114	0.00193	CcSEcCtD
Roflumilast—Feeling abnormal—Orlistat—obesity	0.00114	0.00192	CcSEcCtD
Roflumilast—Skin disorder—Bupropion—obesity	0.00113	0.00191	CcSEcCtD
Roflumilast—Urinary tract infection—Topiramate—obesity	0.00113	0.00191	CcSEcCtD
Roflumilast—Gastrointestinal pain—Orlistat—obesity	0.00113	0.00191	CcSEcCtD
Roflumilast—Feeling abnormal—Sibutramine—obesity	0.0011	0.00186	CcSEcCtD
Roflumilast—Urticaria—Orlistat—obesity	0.0011	0.00185	CcSEcCtD
Roflumilast—Gastrointestinal pain—Sibutramine—obesity	0.00109	0.00185	CcSEcCtD
Roflumilast—Sinusitis—Topiramate—obesity	0.00109	0.00184	CcSEcCtD
Roflumilast—Abdominal pain—Orlistat—obesity	0.00109	0.00184	CcSEcCtD
Roflumilast—Urticaria—Sibutramine—obesity	0.00106	0.00179	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Bupropion—obesity	0.00106	0.00179	CcSEcCtD
Roflumilast—Abdominal pain—Sibutramine—obesity	0.00106	0.00178	CcSEcCtD
Roflumilast—Insomnia—Bupropion—obesity	0.00105	0.00178	CcSEcCtD
Roflumilast—Rhinitis—Topiramate—obesity	0.00105	0.00177	CcSEcCtD
Roflumilast—Connective tissue disorder—Topiramate—obesity	0.00103	0.00173	CcSEcCtD
Roflumilast—Dyspepsia—Bupropion—obesity	0.00103	0.00173	CcSEcCtD
Roflumilast—Hypersensitivity—Orlistat—obesity	0.00102	0.00172	CcSEcCtD
Roflumilast—Decreased appetite—Bupropion—obesity	0.00101	0.00171	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Bupropion—obesity	0.00101	0.0017	CcSEcCtD
Roflumilast—Fatigue—Bupropion—obesity	0.001	0.0017	CcSEcCtD
Roflumilast—Constipation—Bupropion—obesity	0.000997	0.00168	CcSEcCtD
Roflumilast—Asthenia—Orlistat—obesity	0.000991	0.00167	CcSEcCtD
Roflumilast—Hypersensitivity—Sibutramine—obesity	0.000985	0.00166	CcSEcCtD
Roflumilast—Cardiac disorder—Topiramate—obesity	0.00097	0.00164	CcSEcCtD
Roflumilast—Feeling abnormal—Bupropion—obesity	0.000961	0.00162	CcSEcCtD
Roflumilast—Asthenia—Sibutramine—obesity	0.000959	0.00162	CcSEcCtD
Roflumilast—Gastrointestinal pain—Bupropion—obesity	0.000953	0.00161	CcSEcCtD
Roflumilast—Diarrhoea—Orlistat—obesity	0.000945	0.0016	CcSEcCtD
Roflumilast—Immune system disorder—Topiramate—obesity	0.000944	0.00159	CcSEcCtD
Roflumilast—Mediastinal disorder—Topiramate—obesity	0.000942	0.00159	CcSEcCtD
Roflumilast—Urticaria—Bupropion—obesity	0.000926	0.00156	CcSEcCtD
Roflumilast—Abdominal pain—Bupropion—obesity	0.000921	0.00156	CcSEcCtD
Roflumilast—Mental disorder—Topiramate—obesity	0.000916	0.00155	CcSEcCtD
Roflumilast—Diarrhoea—Sibutramine—obesity	0.000915	0.00154	CcSEcCtD
Roflumilast—Dizziness—Orlistat—obesity	0.000914	0.00154	CcSEcCtD
Roflumilast—Malnutrition—Topiramate—obesity	0.00091	0.00154	CcSEcCtD
Roflumilast—Tension—Topiramate—obesity	0.000893	0.00151	CcSEcCtD
Roflumilast—Dysgeusia—Topiramate—obesity	0.000891	0.0015	CcSEcCtD
Roflumilast—Dizziness—Sibutramine—obesity	0.000884	0.00149	CcSEcCtD
Roflumilast—Nervousness—Topiramate—obesity	0.000884	0.00149	CcSEcCtD
Roflumilast—Back pain—Topiramate—obesity	0.00088	0.00149	CcSEcCtD
Roflumilast—Vomiting—Orlistat—obesity	0.000878	0.00148	CcSEcCtD
Roflumilast—Muscle spasms—Topiramate—obesity	0.000875	0.00148	CcSEcCtD
Roflumilast—Rash—Orlistat—obesity	0.000871	0.00147	CcSEcCtD
Roflumilast—Dermatitis—Orlistat—obesity	0.00087	0.00147	CcSEcCtD
Roflumilast—Headache—Orlistat—obesity	0.000866	0.00146	CcSEcCtD
Roflumilast—Hypersensitivity—Bupropion—obesity	0.000859	0.00145	CcSEcCtD
Roflumilast—Tremor—Topiramate—obesity	0.000853	0.00144	CcSEcCtD
Roflumilast—Vomiting—Sibutramine—obesity	0.00085	0.00143	CcSEcCtD
Roflumilast—Ill-defined disorder—Topiramate—obesity	0.000844	0.00143	CcSEcCtD
Roflumilast—Rash—Sibutramine—obesity	0.000843	0.00142	CcSEcCtD
Roflumilast—Dermatitis—Sibutramine—obesity	0.000842	0.00142	CcSEcCtD
Roflumilast—Headache—Sibutramine—obesity	0.000838	0.00141	CcSEcCtD
Roflumilast—Asthenia—Bupropion—obesity	0.000836	0.00141	CcSEcCtD
Roflumilast—Nausea—Orlistat—obesity	0.000821	0.00139	CcSEcCtD
Roflumilast—Malaise—Topiramate—obesity	0.000821	0.00139	CcSEcCtD
Roflumilast—Vertigo—Topiramate—obesity	0.000818	0.00138	CcSEcCtD
Roflumilast—Palpitations—Topiramate—obesity	0.000804	0.00136	CcSEcCtD
Roflumilast—Diarrhoea—Bupropion—obesity	0.000798	0.00135	CcSEcCtD
Roflumilast—Nausea—Sibutramine—obesity	0.000794	0.00134	CcSEcCtD
Roflumilast—Myalgia—Topiramate—obesity	0.000775	0.00131	CcSEcCtD
Roflumilast—Anxiety—Topiramate—obesity	0.000772	0.0013	CcSEcCtD
Roflumilast—Dizziness—Bupropion—obesity	0.000771	0.0013	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000769	0.0013	CcSEcCtD
Roflumilast—Discomfort—Topiramate—obesity	0.000765	0.00129	CcSEcCtD
Roflumilast—Vomiting—Bupropion—obesity	0.000741	0.00125	CcSEcCtD
Roflumilast—Infection—Topiramate—obesity	0.000738	0.00125	CcSEcCtD
Roflumilast—Rash—Bupropion—obesity	0.000735	0.00124	CcSEcCtD
Roflumilast—Dermatitis—Bupropion—obesity	0.000734	0.00124	CcSEcCtD
Roflumilast—Headache—Bupropion—obesity	0.00073	0.00123	CcSEcCtD
Roflumilast—Nervous system disorder—Topiramate—obesity	0.000728	0.00123	CcSEcCtD
Roflumilast—Skin disorder—Topiramate—obesity	0.000721	0.00122	CcSEcCtD
Roflumilast—Nausea—Bupropion—obesity	0.000692	0.00117	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Topiramate—obesity	0.000677	0.00114	CcSEcCtD
Roflumilast—Insomnia—Topiramate—obesity	0.000672	0.00113	CcSEcCtD
Roflumilast—Dyspepsia—Topiramate—obesity	0.000654	0.0011	CcSEcCtD
Roflumilast—Decreased appetite—Topiramate—obesity	0.000646	0.00109	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Topiramate—obesity	0.000641	0.00108	CcSEcCtD
Roflumilast—Fatigue—Topiramate—obesity	0.00064	0.00108	CcSEcCtD
Roflumilast—Constipation—Topiramate—obesity	0.000635	0.00107	CcSEcCtD
Roflumilast—Feeling abnormal—Topiramate—obesity	0.000612	0.00103	CcSEcCtD
Roflumilast—Gastrointestinal pain—Topiramate—obesity	0.000607	0.00103	CcSEcCtD
Roflumilast—Urticaria—Topiramate—obesity	0.00059	0.000996	CcSEcCtD
Roflumilast—Abdominal pain—Topiramate—obesity	0.000587	0.000991	CcSEcCtD
Roflumilast—Hypersensitivity—Topiramate—obesity	0.000547	0.000924	CcSEcCtD
Roflumilast—Asthenia—Topiramate—obesity	0.000533	0.000899	CcSEcCtD
Roflumilast—Diarrhoea—Topiramate—obesity	0.000508	0.000858	CcSEcCtD
Roflumilast—Dizziness—Topiramate—obesity	0.000491	0.000829	CcSEcCtD
Roflumilast—Vomiting—Topiramate—obesity	0.000472	0.000797	CcSEcCtD
Roflumilast—Rash—Topiramate—obesity	0.000468	0.00079	CcSEcCtD
Roflumilast—Dermatitis—Topiramate—obesity	0.000468	0.00079	CcSEcCtD
Roflumilast—Headache—Topiramate—obesity	0.000465	0.000785	CcSEcCtD
Roflumilast—Nausea—Topiramate—obesity	0.000441	0.000745	CcSEcCtD
Roflumilast—PDE4D—adipose tissue—obesity	0.000362	0.122	CbGeAlD
Roflumilast—PDE4D—adrenal gland—obesity	0.000325	0.109	CbGeAlD
Roflumilast—PDE4A—adipose tissue—obesity	0.00032	0.108	CbGeAlD
Roflumilast—PDE4B—islet of Langerhans—obesity	0.000299	0.101	CbGeAlD
Roflumilast—PDE4A—adrenal gland—obesity	0.000287	0.0968	CbGeAlD
Roflumilast—PDE4B—respiratory system—obesity	0.000283	0.0953	CbGeAlD
Roflumilast—PDE4D—liver—obesity	0.000254	0.0856	CbGeAlD
Roflumilast—PDE4B—pituitary gland—obesity	0.000192	0.0646	CbGeAlD
Roflumilast—PDE4B—adipose tissue—obesity	0.000191	0.0644	CbGeAlD
Roflumilast—PDE4B—adrenal gland—obesity	0.000171	0.0577	CbGeAlD
Roflumilast—PDE4B—endocrine gland—obesity	0.000149	0.0501	CbGeAlD
Roflumilast—PDE4B—liver—obesity	0.000134	0.0451	CbGeAlD
Roflumilast—PDE4B—Signaling by GPCR—PRKCB—obesity	0.000101	0.00025	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCL5—obesity	0.000101	0.000249	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—AKT2—obesity	0.0001	0.000248	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PIK3R1—obesity	0.0001	0.000248	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CNR1—obesity	9.97e-05	0.000246	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—POMC—obesity	9.95e-05	0.000246	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRL—obesity	9.93e-05	0.000245	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FOXO3—obesity	9.92e-05	0.000245	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADRB2—obesity	9.89e-05	0.000245	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—LPL—obesity	9.85e-05	0.000244	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TCF7L2—obesity	9.79e-05	0.000242	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—STK11—obesity	9.78e-05	0.000242	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FOXO1—obesity	9.78e-05	0.000242	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RPS6KB1—obesity	9.76e-05	0.000241	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—AKT2—obesity	9.75e-05	0.000241	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SOCS1—obesity	9.74e-05	0.000241	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CCL2—obesity	9.74e-05	0.000241	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—DRD2—obesity	9.73e-05	0.00024	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3CG—obesity	9.67e-05	0.000239	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PLG—obesity	9.67e-05	0.000239	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PIK3CB—obesity	9.67e-05	0.000239	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—RHOA—obesity	9.66e-05	0.000239	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PIK3CD—obesity	9.66e-05	0.000239	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PTPN1—obesity	9.63e-05	0.000238	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GCG—obesity	9.63e-05	0.000238	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SOCS3—obesity	9.62e-05	0.000238	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—AKT2—obesity	9.57e-05	0.000236	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PIK3R1—obesity	9.56e-05	0.000236	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FOXO3—obesity	9.44e-05	0.000233	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GNB3—obesity	9.42e-05	0.000233	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADRB2—obesity	9.42e-05	0.000233	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PIK3CD—obesity	9.37e-05	0.000231	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—TYK2—obesity	9.29e-05	0.00023	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SOCS1—obesity	9.27e-05	0.000229	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PIK3CB—obesity	9.27e-05	0.000229	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IGF2—obesity	9.25e-05	0.000229	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—RHOA—obesity	9.21e-05	0.000228	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—POMC—obesity	9.21e-05	0.000228	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PIK3CD—obesity	9.19e-05	0.000227	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRL—obesity	9.18e-05	0.000227	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GNAS—obesity	9.17e-05	0.000227	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SOCS3—obesity	9.16e-05	0.000226	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PIK3R1—obesity	9.12e-05	0.000225	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PRKCD—obesity	9.08e-05	0.000224	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—STK11—obesity	9.05e-05	0.000224	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CCL2—obesity	9.01e-05	0.000223	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APOB—obesity	8.98e-05	0.000222	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GNB3—obesity	8.97e-05	0.000222	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PLG—obesity	8.95e-05	0.000221	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—RHOA—obesity	8.94e-05	0.000221	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HTR2A—obesity	8.88e-05	0.00022	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—C3—obesity	8.87e-05	0.000219	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—AKT2—obesity	8.85e-05	0.000219	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PIK3R1—obesity	8.84e-05	0.000219	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—TYK2—obesity	8.84e-05	0.000219	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PIK3CB—obesity	8.82e-05	0.000218	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IGF2—obesity	8.81e-05	0.000218	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCL5—obesity	8.77e-05	0.000217	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—RHOA—obesity	8.77e-05	0.000217	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FOXO3—obesity	8.74e-05	0.000216	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GNAS—obesity	8.73e-05	0.000216	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRB2—obesity	8.71e-05	0.000215	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PIK3R1—obesity	8.68e-05	0.000215	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SOCS1—obesity	8.58e-05	0.000212	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—LPL—obesity	8.58e-05	0.000212	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOB—obesity	8.55e-05	0.000211	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FOXO1—obesity	8.52e-05	0.00021	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3CD—obesity	8.5e-05	0.00021	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RPS6KB1—obesity	8.5e-05	0.00021	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SOCS3—obesity	8.48e-05	0.000209	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IRS2—obesity	8.44e-05	0.000209	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AGT—obesity	8.43e-05	0.000208	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PIK3CB—obesity	8.42e-05	0.000208	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCL5—obesity	8.35e-05	0.000206	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GNB3—obesity	8.3e-05	0.000205	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—LEP—obesity	8.26e-05	0.000204	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APOE—obesity	8.26e-05	0.000204	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CAV1—obesity	8.18e-05	0.000202	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—TYK2—obesity	8.18e-05	0.000202	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—LPL—obesity	8.16e-05	0.000202	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APOA1—obesity	8.16e-05	0.000202	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PIK3CB—obesity	8.16e-05	0.000202	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IGF2—obesity	8.15e-05	0.000201	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—RHOA—obesity	8.11e-05	0.000201	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FOXO1—obesity	8.11e-05	0.0002	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RPS6KB1—obesity	8.09e-05	0.0002	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GNAS—obesity	8.08e-05	0.0002	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3R1—obesity	8.03e-05	0.000198	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PIK3CB—obesity	8.01e-05	0.000198	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOB—obesity	7.91e-05	0.000196	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PRKCD—obesity	7.9e-05	0.000195	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ESR1—obesity	7.89e-05	0.000195	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—F2—obesity	7.79e-05	0.000193	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PRKCB—obesity	7.79e-05	0.000193	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HTR2A—obesity	7.73e-05	0.000191	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCL5—obesity	7.73e-05	0.000191	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—C3—obesity	7.72e-05	0.000191	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—BAD—obesity	7.7e-05	0.00019	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—LPL—obesity	7.55e-05	0.000187	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRKCD—obesity	7.52e-05	0.000186	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FOXO1—obesity	7.5e-05	0.000185	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RPS6KB1—obesity	7.49e-05	0.000185	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3CG—obesity	7.45e-05	0.000184	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3CB—obesity	7.41e-05	0.000183	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IRS1—obesity	7.37e-05	0.000182	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HTR2A—obesity	7.36e-05	0.000182	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—C3—obesity	7.35e-05	0.000182	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IRS2—obesity	7.35e-05	0.000182	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AGT—obesity	7.34e-05	0.000181	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—LEP—obesity	7.19e-05	0.000178	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APOE—obesity	7.19e-05	0.000178	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CAV1—obesity	7.12e-05	0.000176	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APOA1—obesity	7.11e-05	0.000176	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—POMC—obesity	7.1e-05	0.000175	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—INS—obesity	7.06e-05	0.000174	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IRS2—obesity	6.99e-05	0.000173	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AGT—obesity	6.98e-05	0.000173	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRKCD—obesity	6.96e-05	0.000172	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCL2—obesity	6.94e-05	0.000172	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ESR1—obesity	6.86e-05	0.00017	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOE—obesity	6.84e-05	0.000169	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—LEP—obesity	6.84e-05	0.000169	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IGF1—obesity	6.82e-05	0.000169	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKT2—obesity	6.82e-05	0.000169	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HTR2A—obesity	6.81e-05	0.000168	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—C3—obesity	6.8e-05	0.000168	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CAV1—obesity	6.78e-05	0.000168	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—F2—obesity	6.78e-05	0.000168	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PRKCB—obesity	6.78e-05	0.000168	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOA1—obesity	6.77e-05	0.000167	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—BAD—obesity	6.7e-05	0.000166	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3CD—obesity	6.55e-05	0.000162	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ESR1—obesity	6.53e-05	0.000161	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—PIK3CA—obesity	6.49e-05	0.00016	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3CG—obesity	6.49e-05	0.00016	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SERPINE1—obesity	6.48e-05	0.00016	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IRS2—obesity	6.47e-05	0.00016	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AGT—obesity	6.46e-05	0.00016	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—F2—obesity	6.45e-05	0.00016	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRKCB—obesity	6.45e-05	0.00016	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IRS1—obesity	6.41e-05	0.000159	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—BAD—obesity	6.38e-05	0.000158	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOE—obesity	6.33e-05	0.000157	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—LEP—obesity	6.33e-05	0.000157	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TYK2—obesity	6.3e-05	0.000156	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CAV1—obesity	6.27e-05	0.000155	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOA1—obesity	6.26e-05	0.000155	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RHOA—obesity	6.25e-05	0.000155	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NOS3—obesity	6.19e-05	0.000153	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3R1—obesity	6.19e-05	0.000153	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—POMC—obesity	6.18e-05	0.000153	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3CG—obesity	6.18e-05	0.000153	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—INS—obesity	6.14e-05	0.000152	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IRS1—obesity	6.11e-05	0.000151	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ESR1—obesity	6.05e-05	0.000149	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCL2—obesity	6.04e-05	0.000149	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—F2—obesity	5.97e-05	0.000148	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRKCB—obesity	5.97e-05	0.000148	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IGF1—obesity	5.94e-05	0.000147	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKT2—obesity	5.94e-05	0.000147	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—BAD—obesity	5.9e-05	0.000146	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PIK3CA—obesity	5.89e-05	0.000146	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—POMC—obesity	5.88e-05	0.000145	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—INS—obesity	5.85e-05	0.000145	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCL2—obesity	5.75e-05	0.000142	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3CG—obesity	5.71e-05	0.000141	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3CB—obesity	5.71e-05	0.000141	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MTOR—obesity	5.71e-05	0.000141	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3CD—obesity	5.7e-05	0.000141	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IGF1—obesity	5.66e-05	0.00014	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKT2—obesity	5.65e-05	0.00014	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PIK3CA—obesity	5.65e-05	0.00014	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IRS1—obesity	5.65e-05	0.00014	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SERPINE1—obesity	5.64e-05	0.000139	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TYK2—obesity	5.49e-05	0.000136	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RHOA—obesity	5.44e-05	0.000135	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—POMC—obesity	5.44e-05	0.000134	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3CD—obesity	5.43e-05	0.000134	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—INS—obesity	5.41e-05	0.000134	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3R1—obesity	5.39e-05	0.000133	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NOS3—obesity	5.39e-05	0.000133	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PIK3CA—obesity	5.38e-05	0.000133	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SERPINE1—obesity	5.37e-05	0.000133	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCL2—obesity	5.32e-05	0.000132	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—AKT1—obesity	5.3e-05	0.000131	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IGF1—obesity	5.23e-05	0.000129	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKT2—obesity	5.23e-05	0.000129	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TYK2—obesity	5.22e-05	0.000129	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—IL6—obesity	5.22e-05	0.000129	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RHOA—obesity	5.18e-05	0.000128	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PIK3CA—obesity	5.13e-05	0.000127	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3R1—obesity	5.13e-05	0.000127	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NOS3—obesity	5.13e-05	0.000127	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3CD—obesity	5.02e-05	0.000124	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PIK3CA—obesity	4.98e-05	0.000123	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MTOR—obesity	4.97e-05	0.000123	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3CB—obesity	4.97e-05	0.000123	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SERPINE1—obesity	4.97e-05	0.000123	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MMP9—obesity	4.96e-05	0.000123	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PIK3CA—obesity	4.88e-05	0.000121	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TYK2—obesity	4.83e-05	0.000119	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MAPK8—obesity	4.83e-05	0.000119	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—AKT1—obesity	4.81e-05	0.000119	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RHOA—obesity	4.79e-05	0.000118	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3R1—obesity	4.74e-05	0.000117	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NOS3—obesity	4.74e-05	0.000117	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MTOR—obesity	4.73e-05	0.000117	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3CB—obesity	4.73e-05	0.000117	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—AKT1—obesity	4.62e-05	0.000114	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—IL6—obesity	4.54e-05	0.000112	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3CA—obesity	4.52e-05	0.000112	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—STAT3—obesity	4.41e-05	0.000109	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—AKT1—obesity	4.39e-05	0.000109	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MTOR—obesity	4.38e-05	0.000108	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3CB—obesity	4.38e-05	0.000108	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL6—obesity	4.32e-05	0.000107	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MMP9—obesity	4.32e-05	0.000107	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MAPK8—obesity	4.2e-05	0.000104	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—AKT1—obesity	4.19e-05	0.000104	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MMP9—obesity	4.11e-05	0.000102	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MYC—obesity	4.1e-05	0.000101	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TGFB1—obesity	4.09e-05	0.000101	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—AKT1—obesity	4.07e-05	0.0001	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL6—obesity	4e-05	9.89e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MAPK8—obesity	4e-05	9.89e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—AKT1—obesity	3.99e-05	9.86e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—STAT3—obesity	3.84e-05	9.5e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MMP9—obesity	3.81e-05	9.41e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MAPK8—obesity	3.7e-05	9.15e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—AKT1—obesity	3.69e-05	9.12e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—STAT3—obesity	3.66e-05	9.04e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MYC—obesity	3.57e-05	8.82e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TGFB1—obesity	3.56e-05	8.8e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3CA—obesity	3.48e-05	8.61e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MYC—obesity	3.4e-05	8.4e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TGFB1—obesity	3.39e-05	8.38e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—STAT3—obesity	3.38e-05	8.36e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MYC—obesity	3.14e-05	7.77e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TGFB1—obesity	3.14e-05	7.75e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6—obesity	3.08e-05	7.62e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3CA—obesity	3.03e-05	7.49e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3CA—obesity	2.88e-05	7.13e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKT1—obesity	2.84e-05	7.03e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6—obesity	2.68e-05	6.63e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3CA—obesity	2.67e-05	6.6e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6—obesity	2.55e-05	6.31e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKT1—obesity	2.48e-05	6.12e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6—obesity	2.36e-05	5.84e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKT1—obesity	2.36e-05	5.83e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKT1—obesity	2.18e-05	5.39e-05	CbGpPWpGaD
